admin – Page 8 – Global Bioclinical

October 28, 2020

Published by admin on October 28, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Oct. 28, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics […]

October 13, 2020

Published by admin on October 13, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel

GAITHERSBURG, Md., Oct. 13, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to […]

September 30, 2020

Published by admin on September 30, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Sept. 30, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat […]

September 15, 2020

Published by admin on September 15, 2020

Categories

GBC Blog

GTEx Consortium Releases Fresh Insights into How DNA Differences Govern Gene Expression

September 10, 2020 – Broad Institute of MIT and Harvard Summary: Scientists have completed a wide-ranging set of studies documenting how small changes in DNA sequence […]

September 8, 2020

Published by admin on September 8, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test

VIENNA, Austria, and GAITHERSBURG, Md., Sept. 08, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today that its subsidiary Ares Genetics GmbH (Vienna, Austria; […]

August 25, 2020

Published by admin on August 25, 2020

Categories

GBC Blog

COVID-19 Is Transmitted Through Aerosols. We Have Enough Evidence, Now It Is Time to Act

Many months into the COVID-19 pandemic, the coronavirus is still spreading uncontrolled through the U.S. Public health authorities including the U.S. Centers for Disease Control and Prevention (CDC) and […]

August 23, 2020

Published by admin on August 23, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19

GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat […]

August 11, 2020

Published by admin on August 11, 2020

Categories

In Vitro Diagnostics - IVD News

New Study Published in the Journal of the National Cancer Institute Concludes that Epi proColon® is the Test of Choice for the Millions of Individuals Not Willing to Participate in FIT or Colonoscopy Screening

BERLIN and SAN DIEGO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that a study published by […]

August 11, 2020

Published by admin on August 11, 2020

Categories

In Vitro Diagnostics - IVD News

OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

VIENNA, Austria, and GAITHERSBURG, Md., Aug. 11, 2020 (GLOBE NEWSWIRE) — Ares Genetics GmbH (Vienna, Austria; “Ares Genetics”), a subsidiary of OpGen, Inc. (Nasdaq: OPGN, “OpGen”), […]